VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 439.7 EUR -1.48%

Market Cap: €113.6B

V	Vertex Pharmaceuticals Inc F:VX1	US
S	Saputo Inc SWB:SB7	CA
G	Genuine Parts Co F:GPT	US
T	Thermo Fisher Scientific Inc XMUN:TN8	US

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

35% > 35%

Exceptional Free Cash Flow Margin

30%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

41% > 30%

Positive ROE

24%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.